Institutional investors hold a majority ownership of TECH through the 99.23% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2017, these large investors purchased a net $654.9 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ATLANTA CAPITAL MANAGEMENT CO. L... Bought 719.0 Thousand shares of Bio-Techne Corp